Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 6/20 | 0.47 |
| ▸ | CA1 | P00915 | 6/20 | 0.47 |
| ▸ | CA2 | P00918 | 6/20 | 0.47 |
| ▸ | CA7 | P43166 | 6/20 | 0.47 |
| ▸ | CA9 | Q16790 | 6/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 6/20 | 0.47 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.46 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CDC7 | O00311 | 2/20 | 0.43 |
| ▸ | DBF4 | Q9UBU7 | 2/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12086751 | 0.82 | ALDH1A1 (0.47) | GSK3BALDH1A1CYP1A2CDC7DBF4 | |
| SCHEMBL14100163 | 0.82 | GSK3B (0.44) | GSK3BCA12CA1CA2CA7 | |
| SCHEMBL9442593 | 0.79 | KDM4E (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL14100166 | 0.76 | GSK3B (0.40) | GSK3BCA12CA1CA2CA7 | |
| SCHEMBL3010802 | 0.76 | ADRA2A (0.46) | GSK3BCA12CA1CA2CA7 | |
| SCHEMBL7034372 | 0.75 | MAPT (0.47) | GSK3BCA12CA1CA2CA9 | |
| SCHEMBL3041792 | 0.74 | MAPT (0.46) | GSK3BCA12CA1CA2CA7 | |
| SCHEMBL9710339 | 0.74 | CA12 (0.52) | GSK3BCA12CA1CA2CA7 | |
| SCHEMBL6030900 | 0.74 | TSHR (0.50) | GSK3BCA12CA1CA2CA7 | |
| SCHEMBL10714962 | 0.74 | CA12 (0.56) | GSK3BCA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1826840-B | Light emitting device and a method of manufacturing thereof | SEMICONDUCTOR ENERGY LAB | 2010-06-23 | — | — | CN | disclosed |
| US-7708908-B2 | Carboxylic acid-modified EDOT for bioconjugation | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-05-04 | — | — | US | disclosed |
| US-20080224099-A1 | CARBOXYLIC ACID-MODIFIED EDOT FOR BIOCONJUGATION | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2008-09-18 | — | — | US | disclosed |
| CN-1826840-A | Light emitting device and a method of manufacturing thereof | SEMICONDUCTOR ENERGY LAB (JP) | 2006-08-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080224099-A1 | CARBOXYLIC ACID-MODIFIED EDOT FOR BIOCONJUGATION | BCAT1, SLC27A1, ACP1 | GSK3B 4845/4885CA12 589/4885CA1 779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.